Strategic Advice and Regulatory Analysis
BlueReg experienced consultants can provide insight into all regulatory requirements for France:
- Drug Registration
- Early Access Programmes
- Post Marketing Authorisation Application (MAA) activities
- Promotional material review
- Quality systems and audits
- Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
- Pricing and reimbursement
The French system for preventing and managing shortages
The French regulation on the prevention and management of stock shortages of medicinal products is...
New Appointment to our Leadership Team !
BlueReg Group is delighted to announce the appointment of Dominique Patrone as General Manager of PharmaBlue....